Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next
Prev

Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents / W2 Holdings, Inc.




Title: Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents.
Abstract: The invention relates to thrombospondin fragments found in plasma, their use or use of portions thereof in diagnostic methods, as method calibrators, method indicators, and as immunogens, and as analytes for methods with substantial clinical utility; and their detection in plasma or other bodily fluids for purpose of diagnostic methods, especially for cancer. ...


Browse recent W2 Holdings, Inc. patents


USPTO Applicaton #: #20120276559
Inventors: Kevin J. Williams


The Patent Description & Claims data below is from USPTO Patent Application 20120276559, Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents.




← Previous       Next →
Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents patent application.

###


Browse recent W2 Holdings, Inc. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents or other areas of interest.
###


Previous Patent Application:
Marker protein for type-2 diabetes
Next Patent Application:
5.9 kda peptide immunoassay method
Industry Class:
Chemistry: molecular biology and microbiology
Thank you for viewing the Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents patent info.
- - -

Results in 1.35712 seconds


Other interesting Freshpatents.com categories:
Electronics: Semiconductor Audio Illumination Connectors Crypto

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-0.0464

66.232.115.224
Browse patents:
Next
Prev

stats Patent Info
Application #
US 20120276559 A1
Publish Date
11/01/2012
Document #
13290296
File Date
11/07/2011
USPTO Class
435/792
Other USPTO Classes
436501
International Class
01N33/566
Drawings
13


Thrombospondin

Follow us on Twitter
twitter icon@FreshPatents

W2 Holdings, Inc.


Browse recent W2 Holdings, Inc. patents



Chemistry: Molecular Biology And Microbiology   Measuring Or Testing Process Involving Enzymes Or Micro-organisms; Composition Or Test Strip Therefore; Processes Of Forming Such Composition Or Test Strip   Involving Antigen-antibody Binding, Specific Binding Protein Assay Or Specific Ligand-receptor Binding Assay   Assay In Which An Enzyme Present Is A Label   Heterogeneous Or Solid Phase Assay System (e.g., Elisa, Etc.)  

Browse patents:
Next
Prev
20121101|20120276559|thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents|The invention relates to thrombospondin fragments found in plasma, their use or use of portions thereof in diagnostic methods, as method calibrators, method indicators, and as immunogens, and as analytes for methods with substantial clinical utility; and their detection in plasma or other bodily fluids for purpose of diagnostic methods, |W2-Holdings-Inc
';